APCC Home Page
history
philosophy
Scientific Advisory Board
about us services our team news contact us
We at APCC believe that the use of predictive behavioral assays is vital to the discovery of novel drugs for the treatment of neurological and psychiatric disorders. Drug discovery is a time-consuming process and any opportunity to reduce the time can be important. Traditionally, behavioral tests have required a great deal of investment in time, expertise and equipment; therefore, the ability to conduct assays rapidly is a great advantage. We use ‘high-throughput’ behavioral assays and parallel testing to provide a competitive edge to our clients.